Highlights

The advanced cancer diagnostics integrating sensor will change the way doctors monitor the disease.

Many clinically important analytes, like viral particles and circulating tumor cells (CTCs), exist at vanishingly small quantities in blood samples. The concentrations may be so small there is a statistical chance of having no target analyte in any given sample, making early detection of disease difficult and impeding the tailoring of ongoing treatment to patient response. This project proposes a novel method of detecting low concentrations of viral particles and CTCs by introducing a new technology to an existing medical procedure. This approach will effectively sample large volumes of blood and vastly change the statistics of analyte quantitation.

Principal Investigator

Michael Cima